These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 22014434)
1. Advances in imaging in Parkinson's disease. Stoessl AJ; Martin WW; McKeown MJ; Sossi V Lancet Neurol; 2011 Nov; 10(11):987-1001. PubMed ID: 22014434 [TBL] [Abstract][Full Text] [Related]
2. Biomarkers for trials of neuroprotection in Parkinson's disease. Agarwal PA; Stoessl AJ Mov Disord; 2013 Jan; 28(1):71-85. PubMed ID: 22927101 [TBL] [Abstract][Full Text] [Related]
3. Neuroimaging in Parkinson's disease: from pathology to diagnosis. Stoessl AJ Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S55-9. PubMed ID: 22166455 [TBL] [Abstract][Full Text] [Related]
4. Imaging insights into basal ganglia function, Parkinson's disease, and dystonia. Stoessl AJ; Lehericy S; Strafella AP Lancet; 2014 Aug; 384(9942):532-44. PubMed ID: 24954673 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the progression of Parkinson's disease: a metabolic network approach. Eckert T; Tang C; Eidelberg D Lancet Neurol; 2007 Oct; 6(10):926-32. PubMed ID: 17884682 [TBL] [Abstract][Full Text] [Related]
6. Neuroimaging: current role in detecting pre-motor Parkinson's disease. Godau J; Hussl A; Lolekha P; Stoessl AJ; Seppi K Mov Disord; 2012 Apr; 27(5):634-43. PubMed ID: 22508281 [TBL] [Abstract][Full Text] [Related]
7. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study. Ekman U; Eriksson J; Forsgren L; Mo SJ; Riklund K; Nyberg L Lancet Neurol; 2012 Aug; 11(8):679-87. PubMed ID: 22742929 [TBL] [Abstract][Full Text] [Related]
8. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Cummings JL; Henchcliffe C; Schaier S; Simuni T; Waxman A; Kemp P Brain; 2011 Nov; 134(Pt 11):3146-66. PubMed ID: 21810889 [TBL] [Abstract][Full Text] [Related]
9. Biomarkers in Parkinson's disease: Advances and strategies. Delenclos M; Jones DR; McLean PJ; Uitti RJ Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S106-10. PubMed ID: 26439946 [TBL] [Abstract][Full Text] [Related]
11. Update on Molecular Imaging in Parkinson's Disease. Liu ZY; Liu FT; Zuo CT; Koprich JB; Wang J Neurosci Bull; 2018 Apr; 34(2):330-340. PubMed ID: 29282614 [TBL] [Abstract][Full Text] [Related]
12. Neuroimaging over the course of Parkinson's disease: from early detection of the at-risk patient to improving pharmacotherapy of later-stage disease. Seibyl J; Russell D; Jennings D; Marek K Semin Nucl Med; 2012 Nov; 42(6):406-14. PubMed ID: 23026362 [TBL] [Abstract][Full Text] [Related]
13. The Future of Brain Imaging in Parkinson's Disease. Helmich RC; Vaillancourt DE; Brooks DJ J Parkinsons Dis; 2018; 8(s1):S47-S51. PubMed ID: 30584163 [TBL] [Abstract][Full Text] [Related]
14. Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects. Kim HJ; Im JH; Yang SO; Moon DH; Ryu JS; Bong JK; Nam KP; Cheon JH; Lee MC; Lee HK J Nucl Med; 1997 Nov; 38(11):1703-11. PubMed ID: 9374337 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease. Nandhagopal R; Kuramoto L; Schulzer M; Mak E; Cragg J; McKenzie J; McCormick S; Ruth TJ; Sossi V; de la Fuente-Fernandez R; Stoessl AJ Brain; 2011 Nov; 134(Pt 11):3290-8. PubMed ID: 22075521 [TBL] [Abstract][Full Text] [Related]
17. New developments of brain imaging for Parkinson's disease and related disorders. Piccini P; Brooks DJ Mov Disord; 2006 Dec; 21(12):2035-41. PubMed ID: 16874751 [TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1. Tzen KY; Lu CS; Yen TC; Wey SP; Ting G J Nucl Med; 2001 Mar; 42(3):408-13. PubMed ID: 11337515 [TBL] [Abstract][Full Text] [Related]